In approaching the problem of vaccination of laboratory workers against psittacosis we decided that it would be advisable to ascertain what could be accomplished with monkeys before anything was attempted with human beings. Consequently, we set out to determine (1) whether monkeys that have recovered from psittacosis pneumonia are refractory to reinfection, (2) whether such monkeys have neutralizing antibodies in their sera, (3) whether large amounts of psittacosis virus administered to monkeys intramuscularly and intravenously produce a serious infection, e.g. psittacosis pneumonia, and (4) whether monkeys that have received repeated small doses of active psittacosis virus intramuscularly, that is vaccinated monkeys, are refractory to intratracheal inoculations of active virus and possess neutralizing antibodies in their sera.
Resistance of Monkeys to Reinfection by Psittacosis Virus
Previous work (2) (3) (4) has evidenced the fact that parrots, rabbits, and mice that have recovered from psittacosis possess a heightened
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resistance to reinfection. I t has also been found possible to produce a psittacosis pneumonia in monkeys (5) b y means of intratracheal injections of active virus. When the present investigation was begun, however, there was no definite evidence available regarding the state of resistance of recovered m o n k e y s to psittacosis virus. Before the vaccination of monkeys was undertaken, it seemed wise to determine whether m o n k e y s t h a t have recovered from psittacosis pneumonia are more refractory to the virus introduced intratracheaUy than are normal control animals. The desired information was obtained in the following manner.
In each of Monkeys t 19, 20, and 22 (see Table I ), a psittacosis pneumonia was produced by means of an intratracheal injection s of 2 cc. of a 1 per cent emulsion in Locke's solution of livers and spleens from mice infected with psittacosis virus. The animals became sick and X-ray pictures of their lungs revealed extensive consolidation. 43 days after the infection in Monkeys 19 and 20 and 105 days after the infection in Monkey 22, each of Monkeys 19, 20, 22, and 28 (normal control animal) received intratracheally 2 cc. of a 1 per cent virus emulsion similar to that described above. Monkey 22 was not sick and X-ray photographs of the lungs showed no consolidation. Monkeys 19 and 20 were not sick, but X-ray pictures showed a slight involvement of their lungs. Monkey 28 (the control), however, was sick and refused to eat, and X-ray photographs of its lungs revealed considerable pneumonia around the hilum and at both bases. Following the X-ray examinations on the 7th day after inoculation the 4 monkeys were sacrificed. The lungs of Monkey 22 were essentially normal macroscopically and microscopicagy. In the gross, the lungs of Monkeys 20 and 19 showed respectively a slight amount of pneumonia of both lower lobes and a few scattered areas of consolidation of the right upper and lower lobes. Stained sections of the consogdated tissues revealed some thickening of the alveolar wags and mononuclear elements in the alveolar spaces. No hemorrhages or areas of necrosis were seen. In Monkey 28 (normal control) practically all of the right lower lobe, half of the left lower lobe, and approximately a quarter of the right upper lobe were consolidated. Stained sections of these lobes showed hemorrhages, areas of necrosis, thickening of the alveolar walls, desquamation of the alveolar epithelium, and mononuclear exudate with fibrin in the alveolar spaces. The gross and microscopic pictures in the lungs of the control Monkey 28 were decidedly different from those found in the lungs of the reinoculated animals, Monkeys 19, 20, and 22. The results of the experiment are summarized in Table I. 1 Approximately half-grown Macacus rhesus monkeys were used in all experiments.
All operations were performed under light ether anesthesia. 
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The experiment just described was repeated and similar results were obtained. From these experiments it is obvious that monkeys that have recovered from psittacosis pneumonia are more refractory to infection by the virus introduced intratracheally than are normal monkeys. From our experience it seems that an increased resistance to psittacosis is acquired slowly. Therefore, one should wait at least a month after the primary inoculation before testing for a heightened resistance in the animals by means of a secondary injection. Moreover, the immunity is only relative, and if too large an amount of virus is administered in the secondary inoculum one will fail to demonstrate a refractory state.
Neutralizing Antibodies in the Sera of Monkeys Recovered from Psittacosis Pneumonia
In addition to determining the presence of a refractory state in monkeys to reinfection by psittacosis virus we attempted to ascertain whether the sera of such animals possess neutralizing antibodies for the active agent. However, when we undertook to demonstrate the presence of the antibodies, it became evident at once that a test in which only a few mice and one or two dilutions of virus are employed is not adequate. We then devised the following test which seems to give satisfactory results.
A 20 per cent liver and spleen emulsion from infected mice was prepared and centrifuged for 10 minutes at 3000 mP.M. The supernatant fluid was collected and decimal dilutions of it were made with Locke's solution. These dilutions were not allowed to stand for any length of time because the virus dies very rapidly under such conditions. Definite amounts of at least four of the dilutions of virus were mixed with equal amounts of the sera being tested. A positive and a negative control serum were run in each experiment. The mixtures were incubated at 37°C. for 2 hours. Then 5 mice 3 were inoculated intraperitoneally with each mixture, each mouse receiving 0.5 cc. The mice were observed for 18 days. The percentage of mice that died and the average time of their death were noted. A summary of an experiment is sl~own in Table II. An examination of the results shown in Table II reveals that more of the mice receiving mixtures of normal serum and virus died than did those receiving virus mixed with the other sera. Furthermore, the average time of death for the former set of mice was shorter than that for the latter. The differences in percentages of deaths and in the average times of death are not strikingly significant when considered separately, but when the two factors are considered together the results of the experiment assume considerable significance. In order to express both factors in one figure we have chosen as a neutralization index the percentage mortality divided by the average time of death. In the manner described the sera from a number of monkeys that had recovered from psittacosis pneumonia 39 to 187 days previously were tested for the presence of neutralizing antibodies and it was found 100 90- 
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Effect of Psittacosis Virus Administered to Monkeys Intravenously and Intramuscularly
Before undertaking the vaccination of monkeys with active virus we wanted to know whether large amounts of psittacosis virus administered intravenously or intramuscularly would produce a serious infection such as a pneumonia. From previous work (5) we had been led to believe that psittacosis virus introduced into monkeys in such a manner is relatively harmless. Nevertheless, 2 experiments, one of which will be described, were performed in order to obtain definite evidence concerning the matter.
A 1 per cent emulsion of livers and spleens from mice sick of psittacosis was made and centrifuged at 3000 R.p.~r. for 5 minutes. The supernatant fluid was removed and used as an inoculum. Monkeys 21 and 25 received respectively 2 cc. of the inoculum intratracheaUy, while each of Monkeys 17 and 18 received 2 cc. of the inoculum mixed with 3 cc. of Locke's solution intravenously and 0.5 cc. of the inoculum intramuscularly. Monkey 25 became very sick and died 5 days after the inoculation. At necropsy an extensive psittacosis pneumonia was found involving all lobes. Monkey 21 became very sick, had fever, and refused to eat. X-ray photographs of the lungs revealed extensive pneumonia. The animal finally recovered, however. Monkeys 17 and 18 were never sick and had no fever. Furthermore, X-ray pictures of their lungs revealed no evidences of pneumonia.
The results of the experiment described above and of a similar one (Monkeys 15, 16, 19, 20) not detailed are shown in Table I and clearly indicate that large amounts of active psittacosis virus can be administered intravenously and intramuscularly to monkeys in relative safety, while similar amounts of virus given intratracheally cause extensive pneumonia which may be fatal.
Vaccination of Monkeys against Psittacosis
At this point we believed that we were ready to proceed with the vaccination of monkeys against psittacosis. To this end 6 experi-
-~ = I06 Table I ) were vaccinated and then tested for immunity. Seven normal monkeys (Nos. 22, 24, 26, 27, 29, 30, 31 in Table I ) were used as controls in the tests. Inasmuch as all of the experiments were conducted in approximately the same manner only one will be described in detail.
Each of Monkeys 3, 4, and 10 received intramuscularly at weekly intervals 3 doses (0.1 cc., 0.15 cc., 1.0 cc.) of active psittacosis ~rus contained in a fresh 10 per cent emulsion of the livers and spleens of infected mice. In addition to these inoculations, Monkey 10 received 2 more weekly injections (1.5 co., 2.0 cc.) of similar emulsions. During the period of vaccination the animals showed no signs of illness and X-ray photographs of their lungs taken from time to time revealed no evidences of pneumonia. 73 days after Monkeys 3 and 4 and 59 days after Monkey 10 had received their last intramuscular injection of virus, they were tested for immunity. Each of these animals and a normal control (Monkey 24) received intratracheally 2 cc. of a 1:100 dilution of a 10 per cent emulsion of livers and spleens from mice sick of psittacosis. The animals were observed carefully and X-ray pictures of all of them were taken on two occasions. The vaccinated monkeys did not become sick and had no fever; X-ray examinations revealed either no evidences or only slight evidences of pneumonia. The normal control monkey became sick, refused to eat, lost weight, became very weak, and had fever; X-ray pictures showed extensive pneumonia. The results of the experiment are graphically portrayed in Text- fig. 2 and are summarized in Table I. The results of the experiment just described in detail and those of 5 other experiments summarized in Table I clearly indicate (1) that repeated intramuscular injections of active psittacosis virus in monkeys are relatively harmless and (2) that such injections produce in monkeys a heightened resistance to active psittacosis virus introduced intratracheally.
Neutralizing Antibodies in the Sera of Vaccinated Monkeys
In addition to the demonstration of the fact that repeated intramuscular injections of active psittacosis virus lead to an increased resistance of monkeys to the active agent it seemed important that we determine whether such treatment is also followed by the appearance of neutralizing antibodies in the sera of vaccinated animals. To this end 8 monkeys were bled before the injections of virus were begun and "again a month or more after their completion. The sera taken before and after immunization were tested at the same time for their ability to neutralize psittacosis virus. Four sets of animals, 2 in each group, were handled in this manner, and the results obtained with one set will be given in detail.
Monkeys 13 and 14 were bled and the sera were pooled and placed in the ice box. Then the animals received 5 weekly intramuscular injections of active psittacosis virus in the manner described in the preceding section of the paper. 33 days after the last injection the animals were bled again and the sera were pooled and inactivated at 56°C. for a half an hour. A neutralization test was made with the sera taken before and after immunization. The results of the experiment are summarized in Table III and Text- fig. 3 .
The results of the above experiment and of 3 others summarized in Table I dearly indicate that repeated intramuscular injections of psittacosis virus led to the appearance of neutralizing antibodies in the sera of the vaccinated monkeys. 
Immunity in Man to Psittacosis
Before proceeding with the vaccination of man against psittacosis it seemed advisable to look for evidence ill regard to whether an attack of the disease protects a human being against reinfection or leads to the appearance of antibodies in the serum of a recovered individual. In the published reports no instances were found in which psittacosis attacked the same individual more than once. This fact, however, is not significant, because the attack rate of the disease is so low that one might not expect a second attack to occur in the same person even though an immune state did not result from the first one. In regard to the presence of antibodies in the sera of human beings convalescent from psittacosis Bedson (6) has shown that weak complement-fixing antibodies may be found. In previous work of ourselves (7) and of Bedson (6) few if any neutralizing antibodies were demonstrated in human convalescent serum. With our improved neutralization test, however, we decided to see whether we could obtain different results.
Neutralization tests were made on sera from 26 individuals. Many of the sera were tested several times and frequently two or more specimens of serum were obtained from an individual. Of the 26 people, 14 gave no history of having had psittacosis, while 12 either had had or were suspected of having had the disease 1 month to 31 years previously. Of the 14 individuals with a negative history, 2 possessed and 12 did not possess demonstrable neutralizing antibodies in their sera. Of the sera from the 12 people with a positive or questionable history of psittacosis, 7 had no demonstrable neutralizing antibodies, 1 gave questionable results, and 4 were able to neutralize appreciable amounts of virus. The results of this work which is shown in the summary of 16 experiments in Table IV reveal the fact that the neutralization test is not a very reliable one for the diagnosis of psittacosis in retrospect. However, inasmuch as many of the individuals had recovered from the disease several years before the tests vcere made, and since it is a well recognized fact (8) that seasoned bird handlers are less likely to contract psittacosis than are novices in the trade, we were not discouraged but proceeded with the vaccination of human beings.
Vaccination of Human Beings against Psittacosis
In approaching the problem of vaccination of human beings against psittacosis we decided that only volunteers would be vaccinated and that the first volunteer must be a physician who had not had the disease and who had no neutralizing antibodies for the virus in his serum. 
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It was further decided that, inasmuch as the period of vaccination is 5 or 6 weeks, during which time the individual might have a cold, the procedure must be safe even under such circumstances. A suitable volunteer presented himself and we waited until he developed a common cold accompanied by a bronchitis before proceeding with the vaccination. As a control another volunteer, a physician, who had had psittacosis 1½ years previously and who had neutralizing antibodies for the virus in his serum was also subjected to vaccination.
Serum was collected from the volunteers before the inoculations of virus were begun. Then each individual received 6 weekly intramuscular inoculations of active psittacosis virus. The amounts of virus and the order of their administration were 0.5 cc. of the following dilutions of 10 per cent emulsions of livers and spleens of infected mice: 1:1000, 1:500, 1:200, 1:100, 1:20, 1:10. The first and last inoculums contained sufficient virus to kill 10,000 and 10,000,000 mice respectively. 1 and 2 weeks after the first injection and 2 and 4 weeks after the last inoculation specimens of serum were collected from each individual for neutralization tests.
The intramuscular injections of psittacosis virus into the two volunteers resulted in no considerable ill effects. The details of the experiment are shown under Cases 1 and 2 in Text- fig. 4 . The person (Case 1) who had not had psittacosis previously had two chills accompanied by a fever of short duration after the second inoculation. The neutralization indices of the sera taken before, during, and after vaccination are recorded in Table IV (Case 1 of Text- fig. 4 is Individual 7 of Table IV , and Case 2 is Individual 2) and plotted in Text- fig. 4 . The results of the neutralization tests on specimens of serum collected from Case 1 are more fully detailed in Table V and are graphically  portrayed in Text- fig. 5 . It is evident from the results of these tests that neutralizing antibodies either appeared or increased in amount as the result of vaccination.
While the work was ill progress we had the opportunity to determine what effect one injection of a moderate amount of active virus would have on an individual who had had psittacosis 3½ years previously and who had no neutralizing antibodies in his serum. Blood was collected and then 0.5 cc. of a 1:100 dilution of a 10 per cent emulsion of livers and spleens from infected mice was given intramuscularly. Specimens of blood were again collected 1 and 2 weeks after the inocu-lation. In Text- fig. 4 (Case 3), Table IV slight discomfort in the individual but induced neutralizing antibodies to appear rapidly in his serum. In this instance the response had the 1: 500, 1: 100, 1 : 50, 1: 10. The individuals suffered no marked ill effects from the injections. In two instances (Cases 4 and 5), however, chills and fever similar to those that occasionally occur after typhoid vaccination were experienced following the last inoculation. The results of the neutralization tests shown in Table IV and Text-figs. 7 and 8 dearly indicate that neutralizing antibodies also appeared in the sera of these volunteers as the result of vaccination.
DISCUSSION
The results of our work indicate that when psittacosis virus produces a pneumonia in man its portal of entry is the upper respiratory tract. The fact is plain that man is very unlikely to contract psittacosis pneumonia as the result of the subcutaneous or intramuscular introduction of active virus. It is not known whether the individuals who have received repeated intramuscular injections of active virus possess an increased resistance to psittacosis in addition to the neutralizing antibodies in their sera, and, if they do possess such a heightened resistance, there is no evidence in regard to the length of time they will retain it. Nevertheless, in view of the results obtained with monkeys, one is justified in assuming that a certain degree of protection against psittacosis was afforded the human volunteers by means of vaccination. Protection of an individual by means of the introduction of an active infectious agent through a portal of entry other than the one used in nature is an old and established procedure. For instance, variolation was employed for many years as a protective measure against smallpox.
SUMMARY
Monkeys that have recovered from psittacosis pneumonia have an increased resistance to infection with the virus and possess neutralizing antibodies in their sera.
Large amounts of active psittacosis virus can be introduced intravenously and intramuscularly into monkeys without the production of a serious infection such as pneumonia. Relatively small amounts of virus introduced intratracheally into monkeys usually lead to psittacosis pneumonia.
Monkeys vaccinated intramuscularly with unattenuated psittacosis virus have an increased resistance to the active agent and possess neutralizing antibodies in their sera. The intramuscular introduction of active psittacosis virus in moderate amounts into human beings is relatively harmless, and repeated inoculations lead to the appearance of neutralizing antibodies in the sera of vaccinated individuals.
